National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.
Answering Your Questions About Cosmeceutical Peptides
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
LC-OCT Demonstrates Non-Invasive Evaluation Capabilities of Dermal Fillers
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Hair-Raising Challenges
Tailoring Aesthetic Treatments for Patients With Skin of Color